Preview: Alopexx, Inc. Set To IPO Tomorrow
Preview: Alopexx, Inc. Set To IPO Tomorrow
Alopexx, Inc.is a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine.Alopexx, Inc. (NASDAQ:ALPX) IPO will take place October, 07 on the NASDAQ exchange under the ticker ALPX.
阿洛比克斯股份有限公司 (納斯達克代碼:ALPX) 首次公開招股將於 10 月 07 日在納斯達克交易所的股票代碼 ALPX 下進行。
The company is offering shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on April 05, 2023.
該公司以每股 5.00 美元的預期價格發售股票，內幕鎖定期為 180 天，截至 2023 年 4 月 5 日。
See also: Benzinga IPO Calendar
另請參閱： 新股上市日曆
About Alopexx, Inc.
關於阿洛比克斯公司
Alopexx, Inc.is a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine.
Aopexx, Inc. 是一家臨床階段生物技術公司，開發新穎的免疫療法，用於預防，治療和緩解細菌，真菌和寄生蟲感染，這些感染表達抗原靶標聚 N-乙酰葡萄糖胺。
See also: Benzinga's Most Shorted Stocks
另請參閱： 本辛加最短空的股票
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由 Beninga 的自動化內容引擎生成，並由編輯審查。
譯文內容由第三人軟體翻譯。
